Biological Technicians

• Glass apparatus1887–1945

  Glass apparatus, reagent preparation, manual microscopy (pre-modern bench era)

  The earliest laboratory assistant's toolkit was almost entirely manual: glass pipettes blown by the assistant or purchased from a supplier, balances weighted with calibrated brass sliders, Bunsen burners for heating, autoclave vessels for sterilization, and the compound microscope for observation. Reagents were prepared from chemical stocks; cell cultures were maintained by hand in glass flasks. The Zeiss compound microscope had reached research-grade resolution by the 1880s; the centrifuge, invented by Gustaf de Laval in 1878, became a standard laboratory instrument by the early twentieth century. In this era the critical skill was not knowledge of any instrument but dexterity in glass handling, sterile technique, and the ability to follow a published protocol with no tolerance for variation.

• Spectrophotometers1945–1965

  Spectrophotometers, ultracentrifuges, early liquid scintillation counting (postwar instrumentation era)

  World War II research accelerated the development of several instruments that transformed the biology laboratory. The Beckman DU spectrophotometer (introduced 1941, widely adopted postwar) allowed technicians to quantify protein and nucleic acid concentrations rapidly from absorbance readings rather than by tedious colorimetric titration. The analytical ultracentrifuge, developed by The Svedberg and commercialized by Spinco (later Beckman) in the late 1940s, enabled the separation of cellular components by density. Liquid scintillation counters for radioactive isotope detection (tritium, carbon-14) arrived in the mid-1950s and became standard in biochemistry and pharmacology labs. Each instrument required a dedicated operator who understood calibration, maintenance, and the specific protocols for each application: this is the era when the laboratory technician stopped being a glorified glass-washer and became an instrument specialist.

• Automated analyzers1965–1985

  Automated analyzers, HPLC, gel electrophoresis (high-volume assay era)

  The late 1960s brought automated continuous-flow analyzers (the Technicon AutoAnalyzer, first commercial model 1957, widely adopted 1965 onward) that could run dozens of biochemical assays per hour without hand-pipetting each sample. High-performance liquid chromatography (HPLC) became practical in the late 1960s and transformed how pharmaceutical and biochemistry labs separated and quantified compounds. Polyacrylamide gel electrophoresis (PAGE) for separating proteins by size, developed in the early 1960s, became a standard bench skill that every biological technician needed by 1970. These tools increased throughput dramatically but also increased the cognitive complexity of the job: a technician operating an AutoAnalyzer or an HPLC system needed to understand equipment maintenance, calibration curves, and quality-control checks that their predecessors had not faced.

  Effect on the work

  Automated analyzers reduced the number of technicians needed for high-volume repetitive assays in clinical and industrial settings, but the growth of academic and pharmaceutical research more than offset this displacement. The net effect over this era was employment expansion, not contraction.

• LIMS1982–2010

  LIMS (Laboratory Information Management Systems, first commercial 1982)

  The first commercial LIMS was introduced in 1982 as a single centralized minicomputer that replaced paper-based sample logs and offered automated reporting. Through the 1980s and 1990s, LIMS evolved to integrate directly with laboratory instruments, automatically ingesting data from spectrophotometers, HPLC systems, and plate readers into structured database records. For the biological technician, LIMS transformed record-keeping from handwritten notebooks that took hours to search into queryable digital archives: sample IDs, reagent lot numbers, instrument readings, and QC results were captured at source and linked. The regulatory implications were significant: FDA's Good Laboratory Practice (GLP) and GMP rules, implemented in 1978, required documented chain of custody and audit trails for every experiment in drug development; LIMS made GLP compliance tractable at scale. By 2000, any technician working in a pharmaceutical or contract research setting was expected to be proficient in at least one LIMS platform.

• PCR thermocyclers1983–2000

  PCR thermocyclers (Cetus/Perkin-Elmer, from 1987 commercial launch)

  Kary Mullis conceived of polymerase chain reaction (PCR) at Cetus Corporation in 1983 during a late-night drive in Northern California; the technique was patented in 1985 and Mullis received the Nobel Prize in Chemistry in 1993. The first commercial thermal cycler, the Perkin-Elmer Cetus DNA Thermal Cycler, launched in 1987. PCR became the single most transformative technique in molecular biology history: it allowed a technician to amplify a specific DNA sequence from a tiny sample in a matter of hours, enabling forensic identification, genetic disease diagnosis, infectious disease detection, and recombinant DNA construction that had previously required weeks of manual cloning. By 1990, PCR competency was the most in-demand technical skill in the biological technician job market. The Human Genome Project (1990-2003) employed thousands of sequencing technicians running PCR-based chain-termination reactions at Sanger-sequencing facilities across the country.

  Effect on the work

  PCR dramatically expanded demand for biological technicians in pharmaceutical, diagnostic, forensic, and academic research settings through the 1990s. The technique is fundamental to virtually every molecular biology workflow; its commercial adoption created a generation of "PCR technicians" whose skills were transferable across sectors.

• Next-generation sequencing platforms2000–2020

  Next-generation sequencing platforms (Illumina, from 2006) and bioinformatics pipelines

  The arrival of massively parallel sequencing (next-generation sequencing, NGS) transformed the scale at which biological technicians worked with DNA and RNA. Illumina's first commercial sequencer, the Genome Analyzer, launched in 2006; by 2010 the platform could sequence a human genome for under $10,000 (versus $3 billion for the Human Genome Project a decade earlier). NGS did not replace the biological technician; it created new preparation tasks (library preparation, quality control with Bioanalyzer, sample normalization) that required precision bench work and new computational literacy (interpreting FastQC output, understanding sequencing run metrics). By 2015, a biological technician in a genomics or precision medicine lab needed both wet-lab skills and the ability to navigate bioinformatics QC tools, making this era a significant credential bifurcation point: technicians who acquired computational skills were paid substantially more than those who did not.

• Robotic liquid handlers2014–present

  Robotic liquid handlers and electronic lab notebooks (Opentrons 2014, Benchling 2012)

  Benchling, founded in 2012, brought electronic lab notebook (ELN) software to a market that had relied on either paper notebooks or expensive legacy LIMS since the 1980s. Opentrons launched its first open-source liquid-handling robot in 2014, making pipetting automation accessible to labs that could not afford a $200,000 Hamilton or Tecan workstation. These tools represent the current inflection point for the biological technician role: the most repetitive bench tasks (serial dilution, PCR plate setup, sample normalization) are automatable by a Python-programmable robot; the most valuable technicians are the ones who write and maintain those protocols rather than pipetting manually. Benchling Copilot (2025) extends this further, using AI to query experimental records and suggest protocol modifications based on prior run data. The emerging split is between technicians who own the automation layer and those who execute manual protocols on instruments that robots have not yet replaced.

  Effect on the work

  Robotic liquid handlers have reduced repetitive pipetting labor in high-throughput settings (pharmaceutical screening, genomics core facilities) by an estimated 30-60% per run, but demand for skilled operators and automation engineers has grown to partially offset this. The overall employment effect has been modest displacement at the lowest-complexity end of the skill distribution, with growth at the automation-literate end.

What's changing in your day

Three parts of your work where AI is already doing real lifting, and what stays yours.